TXMD - TherapeuticsMD, Inc.
1.46
0.060 4.110%
Share volume: 23,057
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.40
0.06
0.04%
Summary score
42%
Profitability
25%
Dept financing
29%
Liquidity
75%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17%
Return on assets
-15.37%
Return on sales
-460.31%
Return on invested capital
207.08%
Total debt ratio
9.78%
Debt ratio change over timeo
0%
Current Ratio
10.53%
Quick Ratio
10.44%
Cash Position Ratio
9.91%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.98%
Return on assets
-15.25%
Return on sales
-461.9%
Return on invested capital
194.71%
Total debt ratio
10.26%
Debt ratio change over timeo
0%
Current Ratio
10.03%
Quick Ratio
9.94%
Cash Position Ratio
9.43%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-9.81%
Return on assets
-9.25%
Return on sales
-335.75%
Return on invested capital
195.63%
Total debt ratio
6.78%
Debt ratio change over time
0%
Current Ratio
14.43%
Quick Ratio
14.31%
Cash Position Ratio
13.63%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TXMD | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -17% | 4.12% | 5.6% | 21.75% |
| Return on assets | -15.37% | 2.87% | 3.58% | 12.86% |
| Return on sales | -460.31% | 20.56% | 28.52% | 43.62% |
| Return on invested capital | 207.08% | 4.34% | 6.5% | -154.84% |
| Profitability | 25% | 23% | 31% | 75% |
| Total debt ratio | 9.78% | 63.22% | 51.03% | 53.2% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 29% | 25% | 20% | 21% |
| Current Ratio | 10.03% | 1.35% | 1.91% | 1.25% |
| Quick Ratio | 9.94% | 0.99% | 1.59% | 0.93% |
| Cash Position Ratio | 9.43% | 0.31% | 0.62% | 0.41% |
| Liquididy | 75% | 7% | 11% | 6% |
| Short-term ratios | TXMD | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -16.98% | 3.9% | 5.53% | 21.28% |
| Return on assets | -15.25% | 2.93% | 3.51% | 12.59% |
| Return on sales | -461.9% | 20.94% | 28.11% | 43.44% |
| Return on invested capital | 194.71% | 4.21% | 6.14% | -151.68% |
| Profitability | 25% | 23% | 30% | 75% |
| Total debt ratio | 10.26% | 64.39% | 51.75% | 53.34% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 29% | 25% | 20% | 21% |
| Current Ratio | 10.03% | 1.35% | 1.91% | 1.25% |
| Quick Ratio | 9.94% | 0.99% | 1.59% | 0.93% |
| Cash Position Ratio | 9.43% | 0.31% | 0.62% | 0.41% |
| Liquididy | 75% | 7% | 10% | 7% |
